Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice

International Journal of Cancer

Volumn 94, Issue 1, 2001, Pages 6-15

  Shim, Winston S N ^a   Teh, Ming ^b   Mack, Peter O P ^c   Ge, Ruowen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Angiopoietin 1; Anti angiogenesis; Antisense RNA; Cancer therapy; Tumor angiogenesis

Indexed keywords

ANGIOPOIETIN 1; COMPLEMENTARY RNA; GROWTH FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HELA CELL; IMMUNE DEFICIENCY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA ANALYSIS; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ANGIOPOIETIN-2; ANIMALS; APOPTOSIS; CELL DIVISION; FEMALE; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BIOSYNTHESIS; PROTEINS; RNA, ANTISENSE;

EID: 0035480022     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1428     Document Type: Article

References (40)

1. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
2. Growth factor acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
3. Vascular-specific growth factors and blood vessel formation
4. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning
5. Angiopoietin-1 induces spouting angiogenesis in vitro
6. Chemotactic properties of angiopoietin-1 and -2, ligand for the endothelial-specific receptor tyrosine kinase Tie2
7. Angiopoietin-1 is an apoptosis survival factor for endothelial cells
8. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
9. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie2 in blood vessel formation
10. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis
11. Signaling vascular morphogenesis and maintenance
12. Increased vascularization in mice overexpressing angiopoietin-1
13. Leakage-resistent blood vessels in mice transgenically overexpressing angiopoietin-1
14. Angiopoietin-1 protects the adult vasculature against plasma leakage
15. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval
16. Cell type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
17. Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
18. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
19. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
20. Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukemia cells
21. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
22. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
23. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograph growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie2 pathway
24. A rapid screening procedure for the identification of high-titer retrovirus packaging clones
25. Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate
26. Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma
27. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis
28. HeLa cell-tumor in nude mice and its response to antitumor agents
29. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their application
30. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
31. Hypoxia-induced apoptosis in human cells with p53 status and function, without any alteration in the nuclear protein level
32. Hypoxia-induced apoptosis in human hepatocellular carcinoma cells: A possible involvement of the 6-TG-sensitive protein kinase(s)-dependent signaling pathway
33. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
34. A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA
35. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
36. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes
37. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
38. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
39. Expression and function of angiopoietin-1 in breast cancer